Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Analysts map a path for UPS through 2026 and beyond, highlighting margin resilience, volume growth, and cost control ...
A sizable stake emerged as H&R Block faced a meaningful slide. This article breaks down what a block stock down inves...
CoreWeave sits at the center of the AI compute boom, offering scalable GPU capacity. This article breaks down the bul...
April brought a notable rebound for UnitedHealth Group Stock. This article breaks down the earnings, margin improveme...
A surprise move in crypto rankings highlights the push and pull around privacy coins. This guide breaks down what zca...
Nvidia sits at the center of the AI boom, but the stock story is complex. This guide explains what's driving Nvidia, ...
As Sprinklr (CXM) gears up for 2027 earnings, investors will scrutinize revenue growth, margins, and customer stickin...
Grilling season arrives as beef prices surge to new highs. Here’s why costs are rising for American shoppers even tho...
Duolingo has solid fundamentals even as its stock underperforms. This article breaks down why a duolingo stock recove...
A director sold 20,000 shares of First Merchants Corp in a move totaling about $835k. This article explains why insid...
After years of setbacks, Intel appears to be turning a corner on its AI ambitions. This article breaks down what to w...